Report Company Directory
- InsiderInsights Weekly Report: November 23, 2024 by InsiderInsights.com
- InsiderInsights.com Daily Ratings Report: November 20, 2024 by InsiderInsights.com
- Aclaris Therapeutics Announces $80 Million Private Placement by GlobeNewsWire
- Aclaris Therapeutics Announces Exclusive, Global License Agreement with Biosion, Inc., adding Potential Best-in-Class Biologics Assets to Pipeline by GlobeNewsWire
- Aclaris Therapeutics Reports Third Quarter 2024 Financial Results and Provides a Corporate Update by GlobeNewsWire
- Aclaris Therapeutics Announces First Patient Dosed in Phase 2a Clinical Trial of ATI-2138, an Investigational Oral Covalent ITK/JAK3 Inhibitor for the Treatment of Moderate to Severe Atopic Dermatitis by GlobeNewsWire
- Aclaris Therapeutics to Participate in the 2024 Cantor Global Healthcare Conference by GlobeNewsWire
- Dropping Coverage of Six Biotech Companies (ACRS, ALLK, COLL, RVNC, SAGE, TVTX) as a Result of Analyst Departure by William Blair
- William Blair’s Transforming Autoimmune Diseases by Targeting CD19 Event on October 16 in New York City by William Blair
- Fast Forward No. 718 by William Blair